Key facts
- Shiru’s last known valuation is $34.0M (Feb 2025).
- It has raised $36.8M; the latest was Later Stage VC in Feb 2026.
- Notable investors include Plug and Play Tech Center, Y Combinator, Climate Capital, Gaingels, Flybridge (New York) — 32 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 32 names
- ·Watchlist + deal alerts for Shiru
- ·The full record, as it builds
Funding rounds
No funding rounds for Shiru are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shiru
Provider of artificial intelligence-powered protein discovery and development services intended to create novel ingredients for food and consumer products. The company offers insights from AI, bioinformatics, and precision biology to discover natural proteins, enabling clients to replace harmful substances.
- Sector
- Healthcare
- HQ
- Berkeley, CA, United States
- Founded
- 2019
- Employees
- 26
- Website
- shiru.com/
- Ownership
- Privately Held (backing)
Shiru doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shiru shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shiru in its N-PORT filings yet. We sweep new filings monthly.